Sandro Feriozzi

The MEST score provides earlier risk prediction in lgA nephropathy

Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich et al. · Kidney International · 2015 · 279 citations · Full text

Mest Score, Glomerulonephritis, Medicine +7

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

Francesco Scolari, Elisa Delbarba, Domenico Santoro et al. · Journal of the American Society of Nephrology · 2021 · 217 citations · Full text

Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Raphael Schiffmann, Derralynn Hughes, Gabor E. Linthorst et al. · Kidney International · 2016 · 175 citations

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 156 citations · Full text

Genome-wide Association Study, Glomerulonephritis, Genome-wide Association +15

Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases

Chiara Fallerini, Laura Dosa, Rossella Tita et al. · Clinical Genetics · 2013 · 140 citations

Relevant Fraction, Next Generation, Mendelian Disorder +14